Filing Details
- Accession Number:
- 0001493152-16-016102
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-12-21 16:02:55
- Reporting Period:
- 2016-12-19
- Filing Date:
- 2016-12-21
- Accepted Time:
- 2016-12-21 16:02:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1360214 | Imprimis Pharmaceuticals Inc. | IMMY | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1274282 | L Mark Baum | C/O Imprimis Pharmaceuticals, Inc 12264 El Camino Real, Suite 350 San Diego CA 92130 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-12-19 | 156,000 | $1.79 | 325,835 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2016-12-19 | 200,000 | $1.72 | 525,835 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-12-19 | 83,709 | $1.72 | 442,126 | No | 4 | D | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | M | Direct | |
| No | 4 | D | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Purchase Warrant | Acquisiton | 2016-12-19 | 156,000 | $0.13 | 156,000 | $1.79 |
| Common Stock | Restricted Stock Unit | Disposition | 2016-12-19 | 200,000 | $0.00 | 200,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 156,000 | 2016-06-23 | 2019-12-23 | No | 4 | P | Direct |
| 0 | No | 4 | M | Direct |
Footnotes
- On December 19, 2016, the Beadore Trust dated March 20, 2015, through which Mr. Baum has voting and investment control over the securities, entered into a definitive agreement to acquire 156,000 Units of Imprimis Pharmaceuticals, Inc.'s (the "Company"), with each Unit consisting of one share of common stock, and a warrant to purchase one share of the Company's common stock, as part of a private placement by the Company to accredited investors.
- On December 19, 2016, restricted stock units granted to Mr. Baum on May 2, 2013, and previously vested, were issued and then transferred into the Beadore Trust dated March 20, 2015. 83,709 shares of common stock were withheld from issuance to Mr. Baum for payroll tax purposes.
- The value of the Purchase Warrant included in each Unit is $0.125.
Billionaire Hedge Funds
